Hyperglycaemia induced by gamma-butyrolactone

Diabet Med. 2022 Aug;39(8):e14850. doi: 10.1111/dme.14850. Epub 2022 Apr 18.

Authors

Lisa M Raven^{1

2

3}, Penny Morris^{1

2

3}, Jerry R Greenfield^{1

2

3}

Affiliations

¹ Department of Diabetes and Endocrinology, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.
² St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
³ Healthy Ageing, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

PMID: 35426170
DOI: 10.1111/dme.14850

No abstract available

Publication types

Letter

MeSH terms

4-Butyrolactone* / adverse effects
Humans
Hyperglycemia* / chemically induced

Substances

4-Butyrolactone